The rates of adverse effects in clinical trials were consistently comparable between people receiving cerebrolysin and those receiving placebo, providing strong evidence that the compound does not introduce meaningful additional risk when used within established dosing parameters
Selank is used for treating anxiety and related disorders, enhancing memory and learning, and modulating pain perception
The compound has been the subject of multiple peer-reviewed studies in human participants and in vitro systems, with results published in BioMed Research International , the Archives of Facial Plastic Surgery , and dermatology and cosmetic-science literature
It received an FDA Breakthrough Therapy designation for non-cirrhotic MASH with moderate-to-advanced fibrosis in 2024, which is a program to speed up development and review not an approval and not permission for clinical use
Why Choose B12 Injections Over Oral Supplements